To evaluate the cost-effectiveness of screening mammography in women 40-49 years old.
A Markov model compared two hypothetical groups ; one underwent screening mammography and the other, observation without mammography.
Variables tested included frequency of mammography, reduction in breast cancer mortality, and cost-effectiveness by age group.
Results were expressed as marginal cost per year of life saved.
If the estimated mortality reduction from mammographic screening was 15% or greater, the marginal cost per year of life saved was comparable to that of other generally accepted medical procedures.
Annual screening with an assumed 30% reduction in mortality had a costeffectiveness similar to that of biennial screening with a 20% reduction.
Mots-clés Pascal : Tumeur, Glande mammaire, Homme, Dépistage, Age 40-49, Femme, Mammographie, Analyse coût efficacité, Glande mammaire pathologie, Radiodiagnostic
Mots-clés Pascal anglais : Tumor, Mammary gland, Human, Medical screening, Age 40-49, Woman, Mammography, Cost efficiency analysis, Mammary gland diseases, Radiodiagnosis
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0489218
Code Inist : 002B24A08. Création : 199501.